These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P. Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432 [Abstract] [Full Text] [Related]
8. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients. Platz KP, Tullius SG, Mueller AR, Schumacher G, Nüssler N, Neuhaus R, Bechstein WO, Lobeck H, Neuhaus P. Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235 [No Abstract] [Full Text] [Related]
10. Long-term immunosuppression after liver transplantation: are steroids necessary? Padbury RT, Gunson BK, Dousset B, Hubscher SG, Mayer AD, Buckels JA, Neuberger JM, Elias E, McMaster P. Transpl Int; 1992 Dec; 5 Suppl 1():S470-2. PubMed ID: 14621849 [Abstract] [Full Text] [Related]
11. Focus on intractable rejection: 6-month results of the European multicentre liver study of FK 506 and cyclosporin A. Bismuth H, Samuel D, Neuhaus P, McMaster P, Calne R, Pichlmayr R, Otto G, Williams R, Groth C. Transpl Int; 1994 Dec; 7 Suppl 1():S3-6. PubMed ID: 11271231 [Abstract] [Full Text] [Related]
12. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion. Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R. Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603 [Abstract] [Full Text] [Related]
13. High incidence of severe infections in heart transplant recipients receiving tacrolimus. Peraira JR, Segovia J, Arroyo R, Ortiz P, Fuertes B, Moñivas V, Burgos R, Alonso-Pulpón L. Transplant Proc; 2003 Aug; 35(5):1999-2000. PubMed ID: 12962875 [Abstract] [Full Text] [Related]
14. Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506. Mor E, Patel T, Glabman S, Sheiner P, Emre S, Guy S, Schwartz M, Miller C. Transpl Int; 1994 Aug; 7 Suppl 1():S77-80. PubMed ID: 11271340 [Abstract] [Full Text] [Related]